The aim of this Bachelor's Thesis is to emphasize the possible danger behind the deposited amounts of gadolinium in various body tissues. This thesis gives an overview of various studies on the topic of gadolinium deposition and it's imapct on surrounding structures. The overview justifies the decisions of health committees around the world to suspend contrast agents based on linear gadolinium since it has been proven the deposition of all types of gadolinium in body tissues, such as brain, bones, liver etc., but it hasn't been proven the clinical-radiological correlation. The only clinical symptom associated with gadolinium deposition is nephrogenic systemic fibrosis (NSF). Recently, agents such as HOPO and DTPA can already be found to reduce retained dose of gadolinium. Except treatment, alternative CEST and D-glucose contrasts are experimentally used to reduce deposition. Currently, the most efficent method for reducing the amount of deposition are stricter measures in order to determine the indications for receiving gadolinium contrast and the use of smaller doses with which an optimal image can still be obtained.